Table 1.
Baseline characteristics between the alive and death group
| Alive (n = 153) | Death (n = 87) | P value | |
|---|---|---|---|
| Age (years) | 73(63 to 80) | 78(71 to 82) | <0.001 |
| Males | 63 (41.2) | 39 (44.8) | 0.582 |
| BMI (kg/m2) | 22.8(20.5 to 24.8) | 22.5(20.2 to 25.5) | 0.418 |
| Medical history: | |||
| DM | 40 (26.1) | 37 (42.5) | 0.009 |
| HTN | 89 (58.2) | 71 (81.6) | <0.001 |
| Congestion | 131 (85.6) | 72 (82.8) | 0.555 |
| De novo HF | 114 (74.5) | 47 (54) | 0.001 |
| COPD | 20 (13.1) | 17 (19.5) | 0.182 |
| CKD | 5 (3.3) | 9 (10.3) | 0.025 |
| IHD | 35(22.9) | 33(37.9) | 0.013 |
| Stroke | 16 (10.5) | 22 (25.3) | 0.002 |
| AF | 28 (18.3) | 20 (23) | 0.383 |
| SBP | 140(120.5 to 158) | 135(119.5 to 157) | 0.352 |
| Echocardiography | |||
| LVESV (mL) | 99(57 to 144.5) | 82(53 to 137) | 0.195 |
| LVEDV (mL) | 183(142 to 236.5) | 169(129 to 214) | 0.072 |
| LVEF (%) | 41(32 to 53) | 44(32 to 55) | 0.388 |
| Laboratory findings | |||
| Hs-CRP (mg/dL) | 0.5(0.2 to 2.4) | 1.1(0.3 to 2.5) | 0.143 |
| Hb (g/dL) | 12.8(11.6 to 14.2) | 12.8(10.4 to 12.9) | <0.001 |
| Cr (mg/dL) | 0.900(0.8 to 1.2) | 1.1(0.8 to 1.3) | 0.002 |
| Na (mmol/L) | 139(137 to 141) | 138(135 to 140) | <0.001 |
| Initial BNP (pg/mL) | 808.4(497.9 to 1325.3) | 872.1(571.3 to 1587.9) | 0.165 |
| Follow up BNP (pg/mL) | 282.5(136.2 to 487.3) | 617.7(319.1 to 1260) | <0.001 |
| (%) Changes of BNP | −66.1(−81.3 to −37.4) | −31.1(−57 to 36.2) | <0.001 |
Values are expressed as median (25th to 75th) or n (%). BMI body mass index, DM diabetes mellitus, HTN hypertension, HF heart failure, COPD chronic obstructive pulmonary disease, CKD chronic kidney disease, IHD ischemic heart disease, left bundle branch block, AF atrial fibrillation, SBP systolic blood pressure, LV left ventricular, ESV end-systolic volume, EDV end-diastolic volume, EF ejection fraction, Hs-CRP high-sensitivity C-reactive protein, Hb Hemoglobin, Cr creatinine, Na sodium, BNP brain natriuretic peptide